Acute and Post-Acute COVID-19 Outcomes Among Immunologically Naïve Adults During Delta Versus Omicron Waves
View ORCID ProfileMargaret K. Doll, Alpana Waghmare, Antje Heit, Brianna Levenson Shakoor, Louise E. Kimball, Nina Ozbek, Rachel L. Blazevic, Larry Mose, Jim Boonyaratanakornkit, Terry L. Stevens-Ayers, Kevin Cornell, Benjamin D. Sheppard, Emma Hampson, Faria Sharmin, Benjamin Goodwin, Jennifer M. Dan, Tom Archie, Terry O’Connor, David Heckerman, Frank Schmitz, Michael Boeckh, View ORCID ProfileShane Crotty
doi: https://doi.org/10.1101/2022.11.13.22282222
Margaret K. Doll
aDepartment of Population Health Sciences, Albany College of Pharmacy & Health Sciences, Albany, NY, USA
PhD, MPHAlpana Waghmare
bDivision of Infectious Diseases, Department of Pediatrics, University of Washington, Seattle, WA, USA
cVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
MDAntje Heit
dAmazon, Inc., Seattle, WA, USA
MD, PhDBrianna Levenson Shakoor
eCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA
BSLouise E. Kimball
cVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
PhDNina Ozbek
cVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
BSRachel L. Blazevic
cVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
BSLarry Mose
cVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
BSJim Boonyaratanakornkit
cVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
MD, PhDTerry L. Stevens-Ayers
cVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
MSKevin Cornell
fSt. Luke’s Medical Center, Ketchum, ID, USA
MSBenjamin D. Sheppard
fSt. Luke’s Medical Center, Ketchum, ID, USA
BSEmma Hampson
fSt. Luke’s Medical Center, Ketchum, ID, USA
BSFaria Sharmin
aDepartment of Population Health Sciences, Albany College of Pharmacy & Health Sciences, Albany, NY, USA
MPHBenjamin Goodwin
eCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA
BSJennifer M. Dan
eCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA
gDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, California, USA
MD, PhDTom Archie
fSt. Luke’s Medical Center, Ketchum, ID, USA
MDTerry O’Connor
fSt. Luke’s Medical Center, Ketchum, ID, USA
hDepartment of Emergency Medicine, University of Washington, Seattle, WA, USA
MDDavid Heckerman
dAmazon, Inc., Seattle, WA, USA
MD, PhDFrank Schmitz
dAmazon, Inc., Seattle, WA, USA
MD, PhDMichael Boeckh
cVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
iDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA
MD, PhDShane Crotty
eCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA
gDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, California, USA
PhDArticle usage
Posted November 14, 2022.
Acute and Post-Acute COVID-19 Outcomes Among Immunologically Naïve Adults During Delta Versus Omicron Waves
Margaret K. Doll, Alpana Waghmare, Antje Heit, Brianna Levenson Shakoor, Louise E. Kimball, Nina Ozbek, Rachel L. Blazevic, Larry Mose, Jim Boonyaratanakornkit, Terry L. Stevens-Ayers, Kevin Cornell, Benjamin D. Sheppard, Emma Hampson, Faria Sharmin, Benjamin Goodwin, Jennifer M. Dan, Tom Archie, Terry O’Connor, David Heckerman, Frank Schmitz, Michael Boeckh, Shane Crotty
medRxiv 2022.11.13.22282222; doi: https://doi.org/10.1101/2022.11.13.22282222
Acute and Post-Acute COVID-19 Outcomes Among Immunologically Naïve Adults During Delta Versus Omicron Waves
Margaret K. Doll, Alpana Waghmare, Antje Heit, Brianna Levenson Shakoor, Louise E. Kimball, Nina Ozbek, Rachel L. Blazevic, Larry Mose, Jim Boonyaratanakornkit, Terry L. Stevens-Ayers, Kevin Cornell, Benjamin D. Sheppard, Emma Hampson, Faria Sharmin, Benjamin Goodwin, Jennifer M. Dan, Tom Archie, Terry O’Connor, David Heckerman, Frank Schmitz, Michael Boeckh, Shane Crotty
medRxiv 2022.11.13.22282222; doi: https://doi.org/10.1101/2022.11.13.22282222
Subject Area
Subject Areas
- Addiction Medicine (362)
- Allergy and Immunology (682)
- Anesthesia (182)
- Cardiovascular Medicine (2719)
- Dermatology (233)
- Emergency Medicine (410)
- Epidemiology (12362)
- Forensic Medicine (10)
- Gastroenterology (781)
- Genetic and Genomic Medicine (4214)
- Geriatric Medicine (394)
- Health Economics (696)
- Health Informatics (2722)
- Health Policy (1012)
- Hematology (369)
- HIV/AIDS (872)
- Medical Education (403)
- Medical Ethics (111)
- Nephrology (449)
- Neurology (3997)
- Nursing (216)
- Nutrition (592)
- Oncology (2104)
- Ophthalmology (600)
- Orthopedics (250)
- Otolaryngology (309)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (475)
- Pediatrics (1141)
- Primary Care Research (464)
- Public and Global Health (6620)
- Radiology and Imaging (1435)
- Respiratory Medicine (881)
- Rheumatology (417)
- Sports Medicine (350)
- Surgery (458)
- Toxicology (57)
- Transplantation (192)
- Urology (171)